English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Amgen Inc.
Press release submission
| Dec 20, 2021
FDA Approves Otezla® (Apremilast) for the Treatment of Adult Patients With Plaque Psoriasis, Regardless of Severity Level
Press release submission
| Sep 5, 2021
New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps
Press release submission
| Mar 15, 2019
AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Carol Ostrow
| Dec 15, 2017
Amgen Foundation commits $500,000 to help southern California wildfire victims
Carol Ostrow
| Dec 10, 2017
Amgen's Repatha wins FDA approval
Carol Ostrow
| Dec 8, 2017
Amgen presents at Evercore conference
Mark Iandolo
| Nov 1, 2017
Cancer information awareness campaign features conversations with Joan Lunden
Kathy Adams
| Oct 22, 2017
Amgen, Boston Children's Hospital team up for study on unusual pain response
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily
| Jul 24, 2025
Long School of Medicine is largest physician trainer in South Texas
Patient Daily
| Jul 25, 2025
Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily
| Jul 25, 2025
Balloon sinuplasty marks 20 years since FDA approval
1
2
3
»
Last »